Larvol Delta - AdvanCell-Announces-First-Patient-Dosed-in-Phase-III-TheraPb-Clinical-Trial-of-212PbADVC001-in-Metastatic-Prostate-Cancer

212 Pb-ADVC001 - AdvanCell Isotopes

https://www.businesswire.com/news/home/20231107589598/en/AdvanCell-Announces-First-Patient-Dosed-in-Phase-III-TheraPb-Clinical-Trial-of-212Pb-ADVC001-in-Metastatic-Prostate-Cancer

Nov 7, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next